Whether or not you partake in the $30 billion legal cannabis market, the legalization of cannabis in parts of the U.S. and Canada has helped to destigmatize and legalize the use of the cannabinoid ...

BERKELEY, Calif., Feb. 23, 2021 /PRNewswire/ -- Demetrix, Inc., a biotechnology company that makes safe, legal, and effective cannabinoids, took another major step towards commercialization today, ...

Researchers at the Berkeley-based startup Demetrix have engineered yeast to produce a variety of cannabinoids using less water, land and energy than traditional farming methods. Co-founded by UC ...

Demetrix has raised $50 million in a first round of venture funding to establish high-volume fermentation production of tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids. Backers ...

Demetrix – one of a new wave of biotech firms producing cannabinoids via biosynthesis (rather than extracting them from cannabis plants) – has commenced 15,000-liter demo-scale fermentation production ...

Cannabinoid-focused biotechnology company Demetrix announced Thursday it secured $50 million in a Series A funding round led by Tuatara Capital. Another investor is Horizons Ventures, which previously ...

EMERYVILLE, Calif., March 4, 2019 /PRNewswire/ -- Demetrix, Inc., a company with world-class expertise in producing nature's ingredients using fermentation, today announced entry into an exclusive ...

Scientists at the University of California at Berkeley have for the first time created cannabis compounds in a lab, instead of by harvesting them from a plant. They detailed their work, which uses ...

The legalization of cannabis has created many opportunities for researchers to study the compounds in the cannabinoid family and discover new uses for them. Demetrix, a synthetic biology company ...

It’s 2021 and regular THC isn’t going to cut it for the budding weed industry. Neither will CBD. Instead, a host of startups are betting that weed consumers will be clamoring for something that nature ...